NIPPONAMC-NETFPHARMA
PHARMABEES
- Last Price
- ₹27.30
- 1D
- -0.26%
- 1W
- —
- 1M
- -0.04%
Day Low ₹27.21Day High ₹27.60
Before you buy
Sun Pharma alone makes up nearly 24% of this index. US FDA drug approvals and rejections can move individual pharma stocks — and Sun Pharma's moves alone can drive this entire ETF.
- Tracks
- Nifty Pharma TRI
- iNAV
- ₹27.42
- NAV
- —
- Premium / Discount
- -0.42%
- 52W Range
- ₹21.46 – ₹28.36
- 1Y Return
- +21.53%
- AUM
- ₹1,666 Cr
- Liquidity
- High
- AMC
- NIPPONAMC-NETFPHARMA
- Listed
- 2021
About this ETF
This ETF tracks the Nifty Pharma index, which holds India's top 20 pharmaceutical companies. India is one of the world's largest drug exporters, and this index covers that entire industry.
Top 10 Holdings
- Sun Pharmaceutical Industries23.79%
- Divis Laboratories9.10%
- Torrent Pharmaceuticals7.90%
- Lupin6.09%
- Dr Reddys Laboratories5.95%
- Cipla5.64%
- Zydus Lifesciences5.09%
- Mankind Pharma4.83%
- Aurobindo Pharma4.54%
- Alkem Laboratories3.68%